Targeted Anodal Stimulation for Spinal Grey Matter: Precision Motor Recovery

This innovative intra-spinal electrical stimulation method selectively activates neuron cell bodies within the grey matter of the spinal cord by utilizing anodal current. By prioritizing the stimulation of motor neuron somata over passing white-matter axons, the technology enables the highly precise and targeted restoration of complex motor functions, such as hand and finger control.

Description

The technology involves a specialized stimulation technique designed to selectively activate motoneuron cell bodies located in the grey matter of the spinal cord, as opposed to conventional methods that mainly target axonal fibers in the white matter. This selective stimulation is achieved via the implantation of electrodes directly into the spinal grey matter, delivering anodal electrical currents tailored to preferentially recruit neuronal somata rather than passing axons. Utilizing biphasic pulse waveforms and precise electrode configurations, the method ensures a focused activation of motor pools, enhancing the specificity of muscle recruitment. Anodal stimulation, in contrast to traditional cathodal approaches, affords improved selectivity by minimizing the activation of non-target muscles, thus enabling refined control of motor outputs. The technique is underpinned by detailed optimization of stimulation parameters—including current amplitude, pulse width, and electrode placement—which collectively facilitate efficient and targeted neuronal excitation. This methodological innovation permits the modulation of spinal circuits with high spatial resolution and presents potential integration possibilities with neuroprosthetic devices and rehabilitative technologies.

Applications

- Restoration and enhancement of motor function in individuals with spinal cord injuries by selective activation of motoneuron pools controlling specific muscles.
- Facilitation of fine motor control, particularly within hand and upper limb musculature, through precise recruitment of targeted motor units.
- Therapeutic intervention for neurological disorders such as stroke and neurodegenerative diseases where motor pathways are impaired but spinal circuits remain viable.
- Integration with neuroprosthetic systems aimed at augmenting voluntary motor outputs via controlled intra-spinal stimulation.
- Use in rehabilitative protocols to promote motor recovery by selectively stimulating functional spinal pathways to reinforce neuroplasticity.

Advantages

- High Selectivity: Anodal intra-spinal stimulation preferentially activates motoneuron somata, enabling targeted muscle contraction and reducing undesired co-activation of adjacent muscles.
- Enhanced Motor Control: By controlling specific motor pools, the technology permits refined movements necessary for complex tasks such as hand dexterity.
- Reduced Side Effects: Compared to cathodal stimulation that broadly recruits axons and causes widespread muscle activation, this method mitigates off-target stimulation, improving patient safety and comfort.
- Compatibility with Existing Neuroprosthetics: The approach can be integrated with implantable devices, facilitating its adoption within current therapeutic and assistive frameworks.
- Potential for Wide Clinical Application: Its applicability spans a range of neurological conditions, offering versatile therapeutic solutions beyond spinal cord injury.

Invention Readiness

The method has undergone preliminary experimental validation demonstrating selective neuronal recruitment through intra-spinal anodal stimulation using optimized electrode designs and stimulation parameters. Initial data support the efficacy of this approach in preferentially activating motoneuron somata with minimized off-target effects. Further studies are required to evaluate long-term biocompatibility, optimize electrode implantation techniques, and assess functional outcomes in preclinical models. Continued development will focus on system miniaturization and integration with neuroprosthetic platforms to facilitate translational application in clinical rehabilitation settings.

IP Status

Patent Pending

Quick Facts:
Reference Number
07374
Technology Type
Therapeutic Modality
Technology Subtype
Other Therapeutic Modality
Therapeutic Areas
Neuroscience
Therapeutic Indications
Multiple Sclerosis (MS)
Tags
Platform Technology
Lead Inventor
Evan Rogers
Department
Med-Neurological Surgery
All Tech Innovators
Marco CapogrossoEvan R. Rogers
Technology Readiness Level
3. Initial proof of concept, in-vivo
Date Submitted
2025-10-20